ASPIRA WOMEN'S HEALTH

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ASPIRA WOMEN'S HEALTH wurde als Wortmarke am 02.11.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 09. Januar 2023

Markenform Wortmarke
Aktenzeichen 1583710
Länder Australien Brasilien Kanada China Europäische Gemeinschaft Großbritannien Israel Indien Japan Mexiko
Basismarke US Nr. , 09. November 2024
Anmeldedatum 02. November 2020
Ablaufdatum 02. November 2030

Markeninhaber

12117 BEE CAVES ROAD,
BUILDING III, SUITE 100
US

Markenvertreter

One International Place, Suite 2000 Boston MA 02110 US

Waren und Dienstleistungen

42 Diagnostic services (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); providing medical and scientific research services; providing medical and scientific research services; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the fields of women's health, genetics, gynecology and cancer; scientific research consulting in the field of genetics; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); product development in the fields of women's health, genetics, gynecology, diagnostics and cancer; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; consulting services in the fields of laboratory testing and diagnostics; diagnostic testing and clinical research services for clinical trials and research studies in the fields of oncology, gynecology and women's health
44 Medical diagnostic services; health assessment services; health risk assessment services; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the fields of gynecological oncology and women's health; genetic testing for diagnostic or treatment purposes; providing medical information; consulting services in the field of women's health; consulting services in the field of diagnostic medical testing; medical consulting services in the fields of women's health, genetics, gynecology, cancer treatment and diagnostics; medical analysis services in the fields of women's health, gynecology, cancer treatment and diagnostics; providing medical information to doctors and patients in the form of reports in the fields of women's health, genetics, gynecology, diagnostics and cancer; providing medical information, consultancy and advisory services in the fields of women's health, genetics, gynecology, diagnostics and cancer; dna screening for medical purposes; genetic counseling; providing diagnostic services in the fields of women's health, genetics, gynecology and cancer
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
05. Januar 2023 2023/1 Gaz JP Ablehnung
22. Dezember 2022 2022/52 Gaz CA Ablehnung
14. März 2022 2022/12 Gaz CA Ablehnung
08. März 2022 2022/11 Gaz BR RAW: Rule 18ter(2)(i) GP following a provisional refusal
02. Februar 2022 2022/10 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
27. Januar 2022 2022/4 Gaz JP Ablehnung
07. Dezember 2021 2021/50 Gaz BR Ablehnung
25. November 2021 2021/47 Gaz MX Ablehnung
27. Oktober 2021 2021/43 Gaz GB RAW: Rule 18ter(2)(i) GP following a provisional refusal
19. Oktober 2021 2021/45 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
22. September 2021 2021/39 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
18. August 2021 2021/33 Gaz CN Ablehnung
03. August 2021 2021/32 Gaz IL Ablehnung
27. Mai 2021 2021/22 Gaz GB Ablehnung
19. April 2021 2021/17 Gaz IN Ablehnung
13. April 2021 2021/16 Gaz AU Ablehnung
07. April 2021 2021/15 Gaz EM Ablehnung
02. November 2020 2021/11 Gaz US Eintragung

ID: 141583710